
Novo Nordisk Wins FDA Nod for High-Dose Wegovy, Expanding GLP-1 Arsenal
Novo Nordisk wins FDA approval for Wegovy HD, a higher-dose version launching in April across 70,000+ U.S. pharmacies, despite modest stock decline.
NVOHIMSFDA approvalclinical trial